Recall of Philips Ingenia 3.0T CX Devices

Source: FDA · United States

Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.

Philips North America is recalling 22 units of Ingenia 3.0T CX with MR Elastography due to potential stiffness value errors in the scan protocol.

What this FDA recall tells you, and what most readers miss

This notice was issued by FDA on May 14, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.

Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to read it as a data point about the issuing system: how quickly FDA detected the hazard, how precise the geographic or product-identifier scope is, and whether similar notices have clustered in the same category or region in the last 90 days. Cluster patterns frequently precede a broader regulatory action, a single localized FDA recall is isolated; three of them within a quarter often indicate a supply-chain, infrastructure, or seasonal driver that will keep producing notices until something structural changes.

For decision-making, Areazine pairs each alert with the original agency URL, the full agency name, and a timestamp so you can verify the notice against the primary source before acting on it. Tags on this item (recall, product-safety, fda, Devices) map to related alerts in the same area of risk - browsing them together gives a clearer picture than any single notice alone, because the shape of an ongoing issue only becomes visible across multiple sequential alerts.

What Happened

Philips North America is recalling certain medical devices due to the potential for stiffness value errors when a specific range of image reconstruction parameters is used in combination with Resoundant's algorithm, leading to incorrect reconstruction voxel size settings in the default MRE scan protocol.

Which Products Are Affected

The affected products are Philips Ingenia 3.0T CX with MR Elastography. Model Numbers: 781271 and 782105. 510(k) Numbers: K173079, K183063, K193215, K213583, K223458, K251397, K251808. A total of 22 units are affected. Specific UDIs for Model 781271 include (01)00884838068452 with various serial numbers: 78017, 78013, 78014, 78034, 78058, 78073, 78075, 78092, 78112, 78123, 78201, 78202, 78215, 78217, 78239, 78247, 78260, 78286, 78287, 78026. For Model 782105, UDIs include (01)00884838098312 with serial numbers: 78532, 78576. Distribution is nationwide in the United States and worldwide to countries including Argentina, Australia, and others.

What You Should Do

Consumers should follow the initial firm notification, which was issued via letter, and contact the recalling firm, Philips North America at 222 Jacobs St, Cambridge, MA 02141-2296, for further instructions.

Why This Matters

This recall involves medical devices that could produce inaccurate results, potentially impacting diagnostic accuracy in healthcare settings; it affects 22 units distributed globally, highlighting the need for precise medical equipment.

Source

FDA Recall Number: Z-1959-2026; for more information, visit the FDA website and search for event ID 98779.

Original source: FDA Official Notice ↗

All FDA Recalls →

Frequently Asked Questions

Common questions about this FDA recall.

What is this FDA recall about?
Philips North America is recalling 22 units of Ingenia 3.0T CX with MR Elastography due to potential stiffness value errors in the scan protocol.
Which agency issued this alert?
This alert was issued by FDA. The original notice is available at the source link at the bottom of this article.
How severe is this alert?
This alert is classified as "medium" severity. Stay informed and follow agency guidance.
What area is affected?
This alert affects United States. Check with FDA for the most current geographic scope.
Where can I find more FDA Recalls updates?
Browse the full FDA Recalls feed on Areazine at areazine.com/recalls/fda/ for the latest updates from FDA and other agencies.